CollPlant Biotechnologies New

CLGN

NASDAQHealth Care

Income Statement

Total Revenue$515K

Gross Profit$-1.11M

Operating Income$-17.25M

EBITDA$-16.02M

EBIT$-17.06M

Pre-tax Income$-12.16M

Net Income$-16.61M

Cash Equivalent$17.36M

Total Debt$3.18M

Book Value$18.89M

Book Value Per Share1.65

Return on Equity (ROE)-123.35%

Return on Assets (ROA)-88.77%

Return on Invested Capital (ROI)-123.35%

Net Profit Margin-3225.05%

Current Ratio4.44

Quick Ratio4.29

Long-Term Debt / Equity0.00